Wolff M. Kirsch,Andrew Crofton,Tanya Freeman,Charles Glabe,SAmuel M. Hudson,Matthew Schrag,Harry Vinters,Matthew Zabel
申请号：
US14382402
公开号：
US20150297674A1
申请日:
2013.03.12
申请国别(地区):
US
年份:
2015
代理人:
摘要：
A substance for treating a cerebral amyloid angiopathy related condition or disease affecting cerebrovasculature in a patient, comprising an inhibitor that causes inhibition of the formation of membrane attack complex of the complement system and a vehicle for transporting the inhibitor into the cerebrovasculature where the inhibition by the inhibitor is sufficient to decrease the incidence of or to prevent the incidence of cytolysis of the smooth muscle cells. A method for treating a cerebral amyloid angiopathy related condition or disease affecting cerebrovasculature in a patient, comprising: a) identifying a patient with a cerebral amyloid angiopathy related condition or disease b) providing one or more than one substance that comprises an inhibitor that causes inhibition of the formation of membrane attack complex of the complement system, c) administering one or more than one dose of the one or more than one substance to the patient.
